Mesothelioma mortality in Europe: Impact of asbestos consumption and simian virus 40

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Leithner, Katharina ^a   Leithner, Andreas ^a   Clar, Heimo ^a   Weinhaeusel, Andreas ^b   Radl, Roman ^a   Krippl, Peter ^a   Rehak, Peter ^a   Windhager, Reinhard ^a   Haas, Oskar A ^c   Olschewski, Horst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Molecular Diagnostics   (Austria)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; ASBESTOSIS; COMORBIDITY; COMPARATIVE STUDY; DRUG CONTAMINATION; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; EUROPE; FEMALE; HUMAN; MALE; MESOTHELIOMA; MORTALITY; PLEURA TUMOR; SEX RATIO; SIMIAN VIRUS 40; STATISTICS; SURVIVAL; SURVIVAL RATE; VIROLOGY; VIRUS INFECTION;

ASBESTOSIS; CAUSALITY; COMORBIDITY; DRUG CONTAMINATION; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; HUMANS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; POLIOVIRUS VACCINES; POLYOMAVIRUS INFECTIONS; SEX DISTRIBUTION; SIMIAN VIRUS 40; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR VIRUS INFECTIONS;

EID: 34248168869     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-44     Document Type: Article

References (122)

1. Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in ten western countries and japan. K Takahashi MS Huuskonen A Tossavainen T Higashi T Okubo J Rantanen, J Occup Health 1999 41 8 11
2. International expert meeting on new advances in the radiology and screening of asbestos-related diseases. A Tossavainen, Scand J Work Environ Health 2000 26 449 454 11103845
3. Continuing increase in mesothelioma mortality in Britain. J Peto JT Hodgson FE Matthews JR Jones, Lancet 1995 345 535 539 10.1016/S0140-6736(95) 90462-X 7776771
4. New developments about the association of SV40 with human mesothelioma. M Carbone HI Pass L Miele M Bocchetta, Oncogene 2003 22 5173 5180 10.1038/sj.onc.1206552 12910254
5. Simian virus 40 and malignant mesothelioma (Review). PG Cerrano B Jasani R Filiberti M Neri F Merlo S De Flora L Mutti R Puntoni, Int J Oncol 2003 22 187 194 12469203
6. Global use of asbestos and the incidence of mesothelioma. A Tossavainen, Int J Occup Environ Health 2004 10 22 25 15070022
7. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. A Tossavainen, Scand J Work Environ Health 1997 23 311 316 9322824
8. The epidemiology of mesothelioma in historical context. JC McDonald AD McDonald, Eur Respir J 1996 9 1932 1942 10.1183/09031936.96.09091932 8880114
9. Malignant pleural mesothelioma. P Baas H Schouwink FA Zoetmulder, Ann Oncol 1998 9 139 149 10.1023/A:1008239116237 9553658
10. Worldwide asbestos supply and consumption trends from 1900-2000. RL Virta,, Survey USG, 2003 03-83
11. Update of predictions of mortality from pleural mesothelioma in the Netherlands. O Segura A Burdorf C Looman, Occup Environ Med 2003 60 50 55 10.1136/oem.60.1.50 12499457
12. Simian virus 40, poliovaccines and human tumors: a review of recent developments. M Carbone P Rizzo HI Pass, Oncogene 1997 15 1877 1888 10.1038/sj.onc.1201375 9365233
13. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenity. M Bocchetta I Di Resta A Powers R Fresco A Tosolini JR Testa HI Pass P Rizzo M Carbone, Proc Natl Acad Sci U S A 2000 97 10214 10219 10954737 10.1073/pnas.170207097
14. SV40 can be reproducibly detected in paraffin-embedded mesothelioma samples. A Cristaudo A Powers A Vivaldi R Foddis G Guglielmi V Gattini R Buselli G Sensales E Ciancia F Ottenga, Anticancer Res 2000 20 895 898 10810373
15. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. R Cutrone J Lednicky G Dunn P Rizzo M Bocchetta K Chumakov P Minor M Carbone, Cancer Res 2005 65 10273 10279 10.1158/0008-5472.CAN-05-2028 16288015
16. Opinion: SV40 and human tumours: myth, association or causality? AF Gazdar JS Butel M Carbone, Nat Rev Cancer 2002 2 957 964 10.1038/nrc947 12459734
17. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. A De Luca A Baldi V Esposito CM Howard L Bagella P Rizzo M Caputi HI Pass GG Giordano F Baldi M Carbone A Giordano, Nat Med 1997 3 913 916 10.1038/nm0897-913 9256285
18. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. N Shivapurkar T Takahashi J Reddy Y Zheng V Stastny R Collins S Toyooka M Suzuki G Parikh S Asplund SH Kroft C Timmons RW McKenna Z Feng AF Gazdar, Cancer Res 2004 64 3757 3760 10.1158/0008-5472.CAN-03- 3307 15172980
19. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. A Hirvonen K Mattson A Karjalainen T Ollikainen L Tammilehto T Hovi H Vainio HI Pass I Di Resta M Carbone K Linnainmaa, Mol Carcinog 1999 26 93 99 10.1002/(SICI)1098-2744(199910)26:2〈93::AID-MC4〉3.0.CO;2-Z 10506753
20. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. A De Rienzo M Tor DH Sterman F Aksoy SM Albelda JR Testa, J Cell Biochem 2002 84 455 459 10.1002/jcb.10058 11813251
21. Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. A Leithner A Weinhaeusel R Windhager R Schlegl P Waldner S Lang M Dominkus A Zoubek HH Popper OA Haas, Cancer Biol Ther 2002 1 375 379 12432250
22. Failure to confirm presence of SV40 sequences in human tumours. M Krainer T Schenk CC Zielinski C Muller, Eur J Cancer 1995 31A 1893 10.1016/0959- 8049(95)00284-P 8541126
23. More about: cell and molecular biology of simian virus 40: implications for human infections and disease [letter; comment]. H Ohgaki H Huang M Haltia H Vainio P Kleihues, J Natl Cancer Inst 2000 92 495 497 10.1093/jnci/92.6.495 10716971
24. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey [see comments]. S Emri T Kocagoz A Olut Y Gungen L Mutti YI Baris, Anticancer Res 2000 20 891 894 10810372
25. Lack of serologic evidence for prevalent simian virus 40 infection in humans. JJ Carter MM Madeleine GC Wipf RL Garcea PA Pipkin PD Minor DA Galloway, J Natl Cancer Inst 2003 95 1522 1530 14559874
26. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. EA Engels RP Viscidi DA Galloway JJ Carter JR Cerhan S Davis W Cozen RK Severson S De Sanjose JS Colt P Hartge, J Natl Cancer Inst 2004 96 1368 1374 15367569
27. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. RP Viscidi DE Rollison E Viscidi B Clayman E Rubalcaba R Daniel EO Major KV Shah, Clin Diagn Lab Immunol 2003 10 278 285 12626455 10.1128/CDLI.10.2.278-285. 2003
28. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. WA Knowles P Pipkin N Andrews A Vyse P Minor DW Brown E Miller, J Med Virol 2003 71 115 123 10.1002/jmv.10450 12858417
29. Isolation of simian virus 40 from a newborn child. G Brandner A Burger D Neumann-Haefelin C Reinke H Helwig, J Clin Microbiol 1977 5 250 252 191469
30. Absence of SV40 and other polyomavirus (JCV, BKV) DNA in primary cutaneous B cell lymphomas. S Gellrich C Schewe W Sterry A Lukowsky, J Invest Dermatol 2005 124 278 279 10.1111/j.0022-202X.2004.23536.x 15654988
31. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. S Bofill-Mas S Pina R Girones, Appl Environ Microbiol 2000 66 238 245 10618230
32. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. JL Melnick S Stinebaugh, Proc Soc Exp Biol Med 1962 965 968 14472428
33. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. F Levi F Lucchini E Negri P Boyle C La Vecchia, Int J Cancer 2004 110 155 169 10.1002/ijc.20097 15069676
34. Three decades of pleural cncer and mesothelioma registry in Austria where asbestos cement was invented. M Neuberger C Vutuc, Int Arch Occup Environ Health 2003 76 161 166 12733090
35. Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. C La Vecchia F Lucchini E Negri P Boyle P Maisonneuve F Levi, Eur J Cancer 1992 28 514 599 10.1016/S0959-8049(05)80091-7 1591077
36. Cancer registration in Belgium: experience from a melanoma registration programme in the province of East-Flanders. L Brochez V E. L Bleyen G De Backer D De Bacquer M Haelterman JM Naeyaert, Arch Public Health 2000 58 263 279
37. Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. S Metintas M Metintas I Ucgun U Oner, Chest 2002 122 2224 2229 10.1378/chest.122.6.2224 12475867
38. SV40 large T-antigen and human pleural mesothelioma. Screening by polymerase chain reaction and tyramine-amplified immunohistochemistry. K Dhaene A Verhulst E Van Marck, Virchows Arch 1999 435 1 7 10.1007/s004280050387 10431839
39. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. M Ramael J Nagels H Heylen S De Schepper J Paulussen M De Maeyer C Van Haesendonck, Eur Respir J 1999 14 1381 1386 10.1183/09031936.99.14613819 10624771
40. Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). R Hubner E Van Marck, Cancer Causes Control 2002 13 121 129 10.1023/A:1014321729038 11936818
41. Detection of oncogenic virus genomes and gene products in lung carcinoma. L Brouchet S Valmary M Dahan A Didier F Galateau-Salle P Brousset B Degano, Br J Cancer 2005 92 743 746 10.1038/sj.bjc.6602409 15700034
42. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. F Galateau-Salle P Bidet Y Iwatsubo E Gennetay A Renier M Letourneux JC Pairon S Moritz P Brochard MC Jaurand F Freymuth, J Pathol 1998 184 252 257 10.1002/(SICI)1096-9896(199803) 184:3<252::AID-PATH15>3.0.CO;2-R 9614376
43. Failure to detect viral genomic sequences of three viruses (herpes simplex, simian virus 40 and adenovirus) in human and rat brain tumors. C Chauvin M Suh C Remy AL Benabid, Ital J Neurol Sci 1990 11 347 357 10.1007/BF02335937 2174028
44. Low incidence of SV40-like sequences in ependymal tumours. FJ Reuther J Löhler J Herms HH Hugo C Schindler F Leithäuser I Melzner P Möller S Scheil, J Pathol 2001 195 580 585 10.1002/path.1005 11745694
45. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. S Weggen TA Bayer A von Deimling G Reifenberger D von Schweinitz OD Wiestler T Pietsch, Brain Pathol 2000 10 85 92 10668898
46. SV40 sequences in human osteosarcoma of German origin. S Heinsohn RB Scholz B Weber B Wittenstein M Werner G Delling B Kempf-Bielack P Setlak S Bielack H Kabisch, Anticancer Res 2000 20 4539 4545 11205301
47. SV40-like sequences in human bone tumors. M Carbone P Rizzo A Procopio M Giuliano HI Pass MC Gebhardt C Mangham M Hansen DF Malkin G Bushart F Pompetti P Picci AS Levine JD Bergsagel RL Garcea, Oncogene 1996 13 527 535 8760294
48. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. N Shivapurkar T Wiethege II Wistuba S Milchgrub KM Muller AF Gazdar, Int J Cancer 2000 85 743 745 10.1002/(SICI)1097- 0215(20000301)85:5<743::AID-IJC24>3.0.CO;2-3 10699959
49. Episomal simian virus 40 genomes in human brain tumors. P Krieg E Amtmann D Jonas H Fischer K Zang G Sauer, Proc Natl Acad Sci U S A 1981 78 6446 6450 6273871 10.1073/pnas.78.10.6446
50. Cloning of SV40 genomes from human brain tumors. P Krieg G Scherer, Virology 1984 138 336 340 10.1016/0042-6822(84)90357-X 6093370
51. Standardized detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. S Heinsohn S Golta H Kabisch U zur Stadt, Haematologica 2005 90 94 99 15642675
52. Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses. C Völter H zur Hausen D Alber EM de Villiers, Virology 1997 237 389 396 10.1006/viro.1997.8772 9356349
53. Association of polyomaviruses JC, SV40, and BK with human brain tumors. K Dörries G Loeber J Meixensberger, Virology 1987 160 268 270 10.1016/0042-6822(87)90071-7 2820135
54. Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients. M Montesinos-Rongen R Besleaga S Heinsohn R Siebert H Kabisch OD Wiestler M Deckert, Virchows Arch 2004 444 436 438 10.1007/s00428-004-1001-9 15042369
55. SV40 and SV40-like viruses as possible risk factors. E Geissler, Arch Geschwulstforsch 1983 53 217 226 6311136
56. Simian virus 40 footprints in normal human tissues, brain and bone tumours of different histotypes. F Martini L Lazzarin L Iaccheri A Corallini M Gerosa C Trabanelli N Calza G Barbanti-Brodano M Tognon, Dev Biol Stand 1998 94 55 66 9776226
57. Presence and expression of the simian virus-40 genome in human giant cell tumors of bone. G Gamberi MS Benassi F Pompetti C Ferrari P Ragazzini MR Sollazzo L Molendini M Merli G Magagnoli F Chiesa AG Gobbi A Powers P Picci, Genes Chromosomes Cancer 2000 28 23 30 10.1002/(SICI)1098-2264(200005)28: 1<23::AID-GCC3>3.0.CO;2-W 10738299
58. SV40, JC and BK expression in tissue, urine and blood samples from patients with malignant and nonmalignant pleural disease. L Strizzi G Vianale M Giuliano R Sacco F Tassi P Chiodera P Casalini A Procopio, Anticancer Res 2000 20 885 889 10810371
59. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. A Procopio L Strizzi G Vianale P Betta R Puntoni V Fontana G Tassi F Gareri L Mutti, Genes Chromosomes Cancer 2000 29 173 179 10.1002/1098-2264(2000)9999:9999<::AID-GCC1019>3.0.CO;2-B 10959097
60. Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands. M Martinelli F Martini E Rinaldi L Caramanico E Magri E Grandi F Carinci A Pastore M Tognon, Am J Pathol 2002 161 1127 1133 12368186
61. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. F Martini L Iaccheri L Lazzarin P Carinci A Corallini M Gerosa P Iuzzolino BG Barbanti M Tognon, Cancer Res 1996 56 4820 4825 8841004
62. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40. A Cristaudo A Vivaldi G Sensales G Guglielmi E Ciancia R Elisei F Ottenga, J Environ Pathol Toxicol Oncol 1995 14 29 34 7473072
63. Human brain tumors and simian virus 40. F Martini M De Mattei L Iaccheri L Lazzarin G Barbanti-Brodano M Tognon M Gerosa, J Natl Cancer Inst 1995 87 1331 7658487
64. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. F Martini L Lazzarin L Iaccheri B Vignocchi G Finocchiaro I Magnani M Serra K Scotlandi G Barbanti-Brodano M Tognon, Cancer 2002 94 1037 1048 10.1002/cncr.10272 11920474
65. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. F Pacini A Vivaldi M Santoro M Fedele A Fusco C Romei F Basolo A Pinchera, Oncogene 1998 16 665 669 10.1038/sj.onc.1201552 9482113
66. Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes. A Vivaldi F Pacini F Martini L Iaccheri F Pezzetti R Elisei A Pinchera P Faviana F Basolo M Tognon, J Clin Endocrinol Metab 2003 88 892 899 10.1210/jc.2002-020436 12574230
67. Investigation of the simian polyomavirus SV40 as a potential causative agent of human neurological disorders in AIDS patients. M Tognon F Martini L Iaccheri R Cultrera C Contini, J Med Microbiol 2001 50 165 172 11211224
68. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. F Martini R Dolcetti A Gloghini L Iaccheri A Carbone M Boiocchi M Tognon, Int J Cancer 1998 78 669 674 10.1002/(SICI)1097- 0215(19981209)78:6<669::AID-IJC1>3.0.CO;2-B 9833757
69. SV40 Enhances the Risk of Malignant Mesothelioma among People Exposed to Asbestos: A Molecular Epidemiologic Case-Control Study. A Cristaudo R Foddis A Vivaldi R Buselli V Gattini G Guglielmi F Cosentino F Ottenga E Ciancia R Libener R Filiberti M Neri P Betta M Tognon L Mutti R Puntoni, Cancer Res 2005 65 3049 3052 15833832
70. Molecular Identification of Simian Virus 40 Infection in Healthy Italian Subjects by Birth Cohort. V Paracchini S Garte P Pedotti F Poli S Frison E Taioli, Mol Med 2005 11 48 51 16032367 10.1007/s00894-004-0220-y
71. Simian virus 40 infection in lymphoproliferative disorders. D Capello D Rossi G Gaudino A Carbone G Gaidano, Lancet 2003 361 88 89 10.1016/S0140- 6736(03)12157-5 12517514
72. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. M De Mattei F Martini A Corallini M Gerosa K Scotlandi P Carinci G Barbanti-Brodano M Tognon, Int J Cancer 1995 61 756 760 7790107
73. Polyomavirus latency and human tumors. M De Mattei F Martini M Tognon M Serra N Baldini G Barbanti-Brodano, J Infect Dis 1994 169 1175 1176 8169418
74. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. J Hernandez-Losa CG Fedele F Pozo A Tenorio V Fernandez J Castellvi C Parada S Ramon y Cajal, Cancer 2005 103 293 298 10.1002/cncr.20801 15593086
75. Lymphoepithelioma-like carcinoma of the uterine cervix. MA Martorell JM Julian C Calabuig JA Garcia-Garcia A Perez-Valles, Arch Pathol Lab Med 2002 126 1501 1505 12456211
76. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas. P Priftakis G Bogdanovic A Hjerpe T Dalianis, Anticancer Res 2002 22 1357 1360 12168811
77. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. H Huang R Reis Y Yonekawa JM Lopes P Kleihues H Ohgaki, Brain Pathol 1999 9 33 42 9989448
78. Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. C Pepper B Jasani H Navabi D Wynford-Thomas AR Gibbs, Thorax 1996 51 1074 1076 8958887
79. Detection of SV40 sequences in human mesothelioma. DJ Griffiths AG Nicholson RA Weiss, Dev Biol Stand 1998 94 127 136 9776233
80. Papovavirus-related RNA sequences in human neurogenic tumours. H Ibelgaufts KW Jones, Acta Neuropathol (Berl) 1982 56 118 122 10.1007/BF00690582 6278814
81. SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival. NA Wong F Rae MM Herriot NJ Mayer DH Brewster DJ Harrison, J Clin Pathol 2003 56 904 909 10.1136/jcp.56.12.904 14645347
82. Simian virus 40 and human pleural mesothelioma. C Mulatero T Surentheran J Breuer RM Rudd, Thorax 1999 54 60 61 10343634
83. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J MacKenzie KS Wilson J Perry A Gallagher RF Jarrett, J Natl Cancer Inst 2003 95 1001 1003 12837836
84. The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. F Mayall K Barratt J Shanks, J Clin Pathol 2003 56 728 730 10.1136/jcp.56.10.728 14514773
85. Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease. CJ Perrons JD Fox SB Lucas NS Brink RS Tedder RF Miller, J Infect 1996 32 205 209 10.1016/S0163-4453(96)80020-X 8793709
86. Some results of the work on mass immunization of the population in the soviet union with live poliovirus vaccine from Albert S. Sabin's strains. MP Chumakov MK Voroshilova SG Drozdov SG Dzagurov VA Lashkevich LL Mironova NM Ralph AV Gagarina IN Dobrova EE Ashmarina GA Shirman GP Fleer EA Tolskaya IS Sokolova LB Elbert KM Sinyak, The control of poliomyelitis by live poliovirus vaccine Budapest, Akadémiai Kiadó, Weissfeiler J, 1961 19 39
87. Methods and results of preparing live poliovirus vaccine without SV40 virus. MP Chumakov SG Dzagurov VA Lashkevich VP Grachev LL Mironova NM Ralf LB Elbert, Poliomyelitis and other enterovirus infections Moscow, Institute of Poliomyelitis and Viral Encephalitides, Chumakov MP, 1963 201 202
88. Human exposure to SV40: review and comment. K Shah N Nathanson, Am J Epidemiol 1976 103 1 12 174424
89. SV40 and human brain tumors. E Geissler, Prog Med Virol 1990 37 211 222 2173847
90. SV40 as a putative human commensal. A Levine J Butel K Dorries J Goedert R Frisque R Garcea A Morris F O'Neill K Shah, Dev Biol Stand 1998 94 245 269 9776246
91. Akutelle Impfprobleme. K Kundratitz, Mitt d österr Sanitätsverw 1962 63 192 198
92. Organisation und Durchführung der ersten Schutzimpfung gegen Kinderlähmung mit Lebendvakzine nach Sabin in Österreich im Winter 1961-1962. F Friza, Mitt d österr Sanitätsverw 1962 63 359 362
93. The organization and results of mass vaccination against poliomyelitis in CSSR. V Skovránek, The control of poliomyelitis by live poliovirus vaccine Budapest, Akadémiai Kiadó, Weissfeiler J, 1961 41 51
94. Live poliovirus vaccination in the USSR, Poland and Czechsolovakia. Chron Wld Hlth Org, 1960 14 142 144
95. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. EA Engels HA Katki NM Nielsen JF Winther H Hjalgrim F Gjerris PS Rosenberg M Frisch, J Natl Cancer Inst 2003 95 532 539 12671021
96. Inactivated poliovirus vaccine: past and present experience. AD Murdin L Barreto S Plotkin, Vaccine 1996 14 735 746 10.1016/0264-410X(95)00211-I 8817819
97. Vaccination with live poliovirus vaccine in the German Democratic Republic. W Belian I Rademacher, The control of poliomyelitis by live poliovirus vaccine Budapest, Akadémiai Kiadó, Weissfeiler J, 1961 53 56
98. Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? An age-period-cohort analysis on Norwegian data from 1953 to 1997. GO Thu LY Hem S Hansen B Moller J Norstein H Nokleby T Grotmol, Int J Cancer 2006 118 8 2035 9 10.1002/ijc.21603 16287082
99. Studies of neutralising antibodies to SV40 in human sera. P Minor P Pipkin Z Jarzebek W Knowles, J Med Virol 2003 70 490 495 10.1002/jmv.10422 12767016
100. Live poliovirus vaccine. Chron Wld Hlth Org 1960 14 137 142
101. Resultados de la Campana nacional de vacunación antipoliomielitica por via oral en Espana. F Perez Gallardo L Valenciano Clavel J Gabriel Y Galan, Rev Sanid Hi Publica 1965 39 537 561
102. Examination of poliovirus vaccine preparations for SV40 sequences. D Sangar PA Pipkin DJ Wood PD Minor, Biologicals 1999 27 1 10 10.1006/biol.1998. 0170 10441397
103. Lack of serological evidence for an association between simian virus 40 and lymphoma. S De Sanjose KV Shah E Domingo-Domenech EA Engels DS Fernandez T Alvaro M Garcia-Villanueva V Romagosa E Gonzalez-Barca RP Viscidi, Int J Cancer 2003 104 522 524 10.1002/ijc.10993 12584752
104. Four years of poliomyelitis research. Chron Wld Hlth Org 1958 12 163 166
105. Poliomyelitis prevention. Chron Wld Hlth Org 1960 14 462 468
106. BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. G Barbanti-Brodano F Martini M De Mattei L Lazzarin A Corallini M Tognon, Adv Virus Res 1998 50 69 99 9520997
107. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. HD Strickler, Cancer Epidemiol Biomarkers Prev 2001 10 523 532 11352864
108. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. JR Testa M Carbone A Hirvonen K Khalili B Krynska K Linnainmaa FD Pooley P Rizzo V Rusch GH Xiao, Cancer Res 1998 58 4505 4509 9788590
109. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. WA Knowles P Pipkin N Andrews A Vyse P Minor DW Brown E Miller, J Med Virol 2003 71 115 123 10.1002/jmv.10450 12858417
110. Cross-reaction of BK virus large T antigen with monoclonal antibodies directed against SV40 large T antigen. RS Mann RB Carroll, Virology 1984 138 379 385 10.1016/0042-6822(84)90365-9 6093375
111. Interspecies-, species- and type-specific T antigenic determinants of human papovaviruses (JC and BK) and of Simian virus 40. E Beth M Cikes L Schloen G di Mayorca G Giraldo, Int J Cancer 1977 20 551 559 72046
112. Simian virus 40 infection of humans. RL Garcea MJ Imperiale, J Virol 2003 77 5039 5045 12692206 10.1128/JVI.77.9.5039-5045.2003
113. Simian virus 40 infection in humans and association with human diseases: results and hypotheses. G Barbanti-Brodano S Sabbioni F Martini M Negrini A Corallini M Tognon, Virology 2004 318 1 9 10.1016/j.virol.2003.09.004 15015494
114. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey. A Senyigit C Babayigit M Gokirmak F Topcu E Asan M Coskunsel R Isik M Ertem, Respiration 2000 67 610 614 10.1159/000056289 11124642
115. Residential proximity to naturally occurring asbestos and mesothelioma risk in california. XL Pan HW Day W Wang LA Beckett MB Schenker, Am J Respir Crit Care Med 2005 172 1019 1025 10.1164/rccm.200412-1731OC 15976368
116. Cancer incidence in five continents. Volume VIII. IARC Sci Publ 2002 1 781 12812229
117. The detection of simian virus 40 in human tumors by polymerase chain reaction. P Rizzo I Di Resta A Powers CM Matker A Zhang L Mutti WM Kast H Pass M Carbone, Monaldi Arch Chest Dis 1998 53 202 210 9689810
118. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. F Lopez-Rios PB Illei V Rusch M Ladanyi, Lancet 2004 364 1157 1166 10.1016/S0140-6736(04)17102-X 15451223
119. SV40 detection in human tumor specimens. M Carbone MA Rdzanek JJ Rudzinski MA De Marco M Bocchetta NM Ramos B Mossman HI Pass, Cancer Res 2005 65 10120 10121 10.1158/0008-5472.CAN-05-1911 16267039
120. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. I Roushdy-Hammady J Siegel S Emri JR Testa M Carbone, Lancet 2001 357 444 445 10.1016/S0140-6736(00)04013-7 11273069
121. Association of SV40 with human tumours. B Jasani A Cristaudo SA Emri AF Gazdar A Gibbs B Krynska C Miller L Mutti C Radu M Tognon A Procopio, Semin Cancer Biol 2001 11 49 61 10.1006/scbi.2000.0346 11243899
122. SV40-immortalized human fibroblasts as a source of SV40 infectious virions. C Morelli F Barbisan L Iaccheri M Tognon, Mol Med 2004 10 112 116 15702218 10.1007/s00894-004-0181-1